Cargando…

Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only cure for patients with severe combined immunodeficiency (SCID). The purpose of this study was to evaluate long-term neurodevelopment of patients with SCID following myeloablative chemotherapy and HSCT. MATERIALS AND METHODS: Sixt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Malinda, Epport, Karen, Azen, Colleen, Parkman, Robertson, Kohn, Donald B., Shah, Ami J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102058/
https://www.ncbi.nlm.nih.gov/pubmed/18807155
http://dx.doi.org/10.1007/s10875-008-9250-z
_version_ 1783511744524582912
author Lin, Malinda
Epport, Karen
Azen, Colleen
Parkman, Robertson
Kohn, Donald B.
Shah, Ami J.
author_facet Lin, Malinda
Epport, Karen
Azen, Colleen
Parkman, Robertson
Kohn, Donald B.
Shah, Ami J.
author_sort Lin, Malinda
collection PubMed
description BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only cure for patients with severe combined immunodeficiency (SCID). The purpose of this study was to evaluate long-term neurodevelopment of patients with SCID following myeloablative chemotherapy and HSCT. MATERIALS AND METHODS: Sixteen pediatric patients diagnosed with SCID were tested using the Bayley Scales of Infant Development and the validated Vineland Adaptive Behavior Scales (VABS) pre- and 1-year post-HSCT. Three years post-HSCT, there were 11 patients available for testing and four patients available 5 years post-HSCT. Patients greater than 3 years of age were administered the Wechsler Preschool and Primary Scale of Intelligence. Both raw scores and scaled scores were analyzed. RESULTS: There was a significant decrease 1 year post-HSCT in the Bayley Mental Developmental Index (MDI) [92.5 (pre) vs. 70.81 (1 year post), p < 0.0001] and the VABS [99.73 (pre) vs. 79.87 (1 year post), p = <0.0001]. There was a significant decrease over time in the MDI [95.00 (pre) vs. 72.64 (1 year post) vs. 71.82 (3 years post), p < 0.0001], but no significant change between 1 and 3 years post-HSCT. There was no change in the Bayley Psychomotor Development Scale (PDI) [82.4 (pre) vs. 84.8 (1 year post), p = 0.68]. The PDI scores decreased over time [86.29 (pre) vs. 86 (1 year post) vs. 74.14 (3 years post), p = 0.045]. Although there was a decrease in scaled scores, there was not a loss of skills. Analysis of raw scores showed that there was an increase in the raw test scores, which indicated that these children acquired developmental skills, but at a slower rate than normal infants and toddlers. Younger children had a more significant decrease in adaptive scores compared with older children. CONCLUSIONS: These findings may reflect the effects of the isolation and prolonged hospitalization that characterizes the immediate post-transplant period. Patients miss out on social interactions and learning opportunities that normally occur at their respective stages of development. These restrictions keep patients from acquiring developmentally appropriate cognitive skills as well as gross and fine motor developmental milestones. Longitudinal follow-up will be important to quantify acquisition of skills.
format Online
Article
Text
id pubmed-7102058
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-71020582020-03-31 Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT) Lin, Malinda Epport, Karen Azen, Colleen Parkman, Robertson Kohn, Donald B. Shah, Ami J. J Clin Immunol Article BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only cure for patients with severe combined immunodeficiency (SCID). The purpose of this study was to evaluate long-term neurodevelopment of patients with SCID following myeloablative chemotherapy and HSCT. MATERIALS AND METHODS: Sixteen pediatric patients diagnosed with SCID were tested using the Bayley Scales of Infant Development and the validated Vineland Adaptive Behavior Scales (VABS) pre- and 1-year post-HSCT. Three years post-HSCT, there were 11 patients available for testing and four patients available 5 years post-HSCT. Patients greater than 3 years of age were administered the Wechsler Preschool and Primary Scale of Intelligence. Both raw scores and scaled scores were analyzed. RESULTS: There was a significant decrease 1 year post-HSCT in the Bayley Mental Developmental Index (MDI) [92.5 (pre) vs. 70.81 (1 year post), p < 0.0001] and the VABS [99.73 (pre) vs. 79.87 (1 year post), p = <0.0001]. There was a significant decrease over time in the MDI [95.00 (pre) vs. 72.64 (1 year post) vs. 71.82 (3 years post), p < 0.0001], but no significant change between 1 and 3 years post-HSCT. There was no change in the Bayley Psychomotor Development Scale (PDI) [82.4 (pre) vs. 84.8 (1 year post), p = 0.68]. The PDI scores decreased over time [86.29 (pre) vs. 86 (1 year post) vs. 74.14 (3 years post), p = 0.045]. Although there was a decrease in scaled scores, there was not a loss of skills. Analysis of raw scores showed that there was an increase in the raw test scores, which indicated that these children acquired developmental skills, but at a slower rate than normal infants and toddlers. Younger children had a more significant decrease in adaptive scores compared with older children. CONCLUSIONS: These findings may reflect the effects of the isolation and prolonged hospitalization that characterizes the immediate post-transplant period. Patients miss out on social interactions and learning opportunities that normally occur at their respective stages of development. These restrictions keep patients from acquiring developmentally appropriate cognitive skills as well as gross and fine motor developmental milestones. Longitudinal follow-up will be important to quantify acquisition of skills. Springer US 2008-09-20 2009 /pmc/articles/PMC7102058/ /pubmed/18807155 http://dx.doi.org/10.1007/s10875-008-9250-z Text en © Springer Science+Business Media, LLC 2008 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Lin, Malinda
Epport, Karen
Azen, Colleen
Parkman, Robertson
Kohn, Donald B.
Shah, Ami J.
Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
title Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
title_full Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
title_fullStr Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
title_full_unstemmed Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
title_short Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
title_sort long-term neurocognitive function of pediatric patients with severe combined immune deficiency (scid): pre- and post-hematopoietic stem cell transplant (hsct)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102058/
https://www.ncbi.nlm.nih.gov/pubmed/18807155
http://dx.doi.org/10.1007/s10875-008-9250-z
work_keys_str_mv AT linmalinda longtermneurocognitivefunctionofpediatricpatientswithseverecombinedimmunedeficiencyscidpreandposthematopoieticstemcelltransplanthsct
AT epportkaren longtermneurocognitivefunctionofpediatricpatientswithseverecombinedimmunedeficiencyscidpreandposthematopoieticstemcelltransplanthsct
AT azencolleen longtermneurocognitivefunctionofpediatricpatientswithseverecombinedimmunedeficiencyscidpreandposthematopoieticstemcelltransplanthsct
AT parkmanrobertson longtermneurocognitivefunctionofpediatricpatientswithseverecombinedimmunedeficiencyscidpreandposthematopoieticstemcelltransplanthsct
AT kohndonaldb longtermneurocognitivefunctionofpediatricpatientswithseverecombinedimmunedeficiencyscidpreandposthematopoieticstemcelltransplanthsct
AT shahamij longtermneurocognitivefunctionofpediatricpatientswithseverecombinedimmunedeficiencyscidpreandposthematopoieticstemcelltransplanthsct